[Clinical experience with potassium hetacillin 9versapen 'Bristol') against dysentery, dysentery-like salmonellosis].
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004403:Dysentery / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010403:Penicillin Resistance; D010406:Penicillins / Q000009:adverse effects / Q000627:therapeutic use; D011188:Potassium / Q000009:adverse effects / Q000627:therapeutic use; D012480:Salmonella Infections / Q000188:drug therapy*; D013844:Thiazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D010406:Penicillins; D013844:Thiazoles; D011188:Potassium